Inclusion of ethnicity in Special Authority criteria improves access to medications for Māori and Pacific peoples with type 2 diabetes
N Z Med J
.
2023 Apr 28;136(1574):93-97.
Authors
Ryan Paul
1
,
Rawiri Keenan
2
,
Mark Rodrigues
2
,
Leanne Te Karu
3
,
Penny Clarke
4
,
Rinki Murphy
5
,
Timothy Kenealy
6
,
Joseph Scott-Jones
7
,
Allan Moffitt
8
,
Ross Lawrenson
1
,
Lynne Chepulis
2
Affiliations
1
Medical Research Centre, University of Waikato, Hamilton; Te Whatu Ora Waikato, New Zealand.
2
Medical Research Centre, University of Waikato, Hamilton, New Zealand.
3
School of Pharmacy, University of Otago, New Zealand.
4
Northcare Medical Centre, Hamilton, New Zealand.
5
Faculty of Medical and Health Sciences, University of Auckland; Te Whatu Ora Counties / Te Toka Tumai Auckland, New Zealand.
6
Faculty of Medical and Health Sciences, University of Auckland, New Zealand.
7
Midlands Health Network, Hamilton, New Zealand.
8
Procare Health Limited, Auckland, New Zealand.
PMID:
37501235
No abstract available
Publication types
Letter
MeSH terms
Diabetes Mellitus, Type 2* / drug therapy
Diabetes Mellitus, Type 2* / ethnology
Ethnicity*
Health Services Accessibility* / statistics & numerical data
Humans
Maori People
New Zealand
Pacific Island People
Grants and funding
Health Research Council